Patent Yard Sign in
Canadian application, no grantCanada

Peptidomimetic inhibitors of post-proline cleaving enzymes

CA 2468192 A1 · Owner: Bachovchin, William W. · Inventors: Bachovchin, William W.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to inhibitors of post-proline cleaving enzymes such as inhibitors of dipeptidyl peptidase IV as well as pharmaceutical , compositions thereof and methods for using such inhibitors. In particular the inhibitors of the present invention are improved over those in the prior art by selection of particular classes of sidechains in the P1 and/or P2 position of the inhibitor. The compounds of the present invention can have a better therapeutic index, owing in part to reduced toxicity and/or improved specificity for the targeted protease.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 26, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 26, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 26, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 26, 2002
GrantedNo grant recorded
Term endedNovember 26, 2022
Patent numberCA 2468192 A1
Classification (IPC)C07K5/06 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedNov 26, 2002Term endedNov 26, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.